Dive Brief: Abiomed on Thursday outlined plans to start a “wave of clinical studies” to counter research papers suggesting its Impella heart pump is more expensive and dangerous than alternatives. The two large observational studies presented at a medical meeting…
Verily plans digital ophthalmology joint venture with Santen
Verily is planning a digital ophthalmology joint venture with Japan’s specialist in the field, Santen. The joint venture does not yet have a name but aims to use machine learning and artificial intelligence techniques, as well as connected and integrated…
